Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE2626.80162.15 (+6.58 %)
PREV CLOSE () 2464.65
OPEN PRICE () 2465.00
BID PRICE (QTY) 2624.50 (6)
OFFER PRICE (QTY) 2629.05 (16)
VOLUME 9525
TODAY'S LOW / HIGH ()2465.00 2638.95
52 WK LOW / HIGH ()1502.45 2700
NSE2627.20160.1 (+6.49 %)
PREV CLOSE() 2467.10
OPEN PRICE () 2470.00
BID PRICE (QTY) 2627.30 (14)
OFFER PRICE (QTY) 2630.30 (4)
VOLUME 267247
TODAY'S LOW / HIGH() 2470.00 2639.70
52 WK LOW / HIGH ()1500.3 2699
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

C C Paarthipan - Chairman Sridhar Ganesan - Managing Director

Registered Office :

Address : 3rd Floor, “ Ashvich Towers”,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096

Phone : 044-24968000 / 8012772888 / 71148000

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE
NEWS
15May Caplin Point Laboratories’ arm gets US
Caplin Point Laboratories’ subsidiary -- Caplin Steriles (CSL) has been..
14May Caplin Point Laboratories informs abou
Further to intimation dated May 07, 2026, Caplin Point Laboratories has..
05May Caplin Point’s arm gets USFDA’s approv
Caplin Point Laboratories’ subsidiary -- Caplin Steriles (CSL) has been..
05May Caplin Point gains as its arm gets USF
Caplin Point Laboratories is currently trading at Rs. 1738.60, up by 2.7..
13Mar Caplin Point’s arm gets USFDA’s final
Caplin Point Laboratories’ subsidiary -- Caplin Steriles (CSL) has recei..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit10953965.8
Gross Profit 1377.2 5075.2
Operating Profit 1446.75331.5
Net Sales 1913.67383.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 19072.10 (2.70%)
M.Cap ( in Cr)
24408.86
Divi's Laboratories (BSE)
 7444.55 (2.73%)
M.Cap ( in Cr)
197641.36
Astrazeneca Pharma (BSE)
 8189.00 (2.36%)
M.Cap ( in Cr)
20384.88
Hester Biosciences (BSE)
 2536.65 (7.28%)
M.Cap ( in Cr)
2157.89
Acutaas Chemicals (BSE)
 3386.30 (3.97%)
M.Cap ( in Cr)
27724.02
Shareholding Pattern
PROMOTERS 70.57%
NON-INSTITUTION 21.18%
MUTUAL FUNDS/UTI 2.03%
FI/BANKS/INSURANCE 0.03%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX76746.99687.22 (0.90%)
NIFTY23956.25188.80 (0.79%)
Dow Jones 51947.25235.60 (0.46%)
Nasdaq 24975.82-161.87 (-0.64%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI